In this project sponsored by sponsored by Merck a leading manufacturer of immunotherapy agents our aim is to develop novel platforms for high concentration antibody formulations. For this purpose, we have combined hydrogel particles with crystalline antibodies to generate a novel strategy for high concentration protein formulations.
